Valvosoft Registry for Aortic Valve Disease
Part of Heart & circulation clinical trials.
This registry tracks outcomes for patients with calcified aortic valve narrowing who are not ready for or are declining traditional surgery. The trial collects real-world data on how patients do with Valvosoft treatment over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have calcified aortic valve narrowing (stiff, narrow aortic valve) that your heart team hasn't recommended immediate surgery for, or you've chosen not to have surgery
- You're willing to sign a consent form and commit to follow-up appointments
- You don't have a prosthetic (artificial) aortic valve already in place
- Your chest skin is intact with no significant scars, burns, or injuries that would prevent contact with the Valvosoft device
- If female, you are not pregnant or breastfeeding
- You have no severe chest deformity that would prevent the device from fitting properly against your chest
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This trial tests a new version of a heart valve (SAPIEN X4) placed without open-heart surgery. It's for people with severe aortic stenosis who have symptoms like shortness of breath or chest pain.
This study is tracking how well the Myval valve works in people with severe aortic stenosis who get it through a minimally invasive procedure called TAVI. It helps doctors learn more about the valve's safety and performance in real-world use.
This study tests a new computer software that helps doctors place a replacement heart valve more precisely. It's for people with severe aortic stenosis who need a transcatheter aortic valve replacement (TAVR).
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This study follows adults who are having aortic valve replacement to better understand outcomes across different hospitals in Europe. It may help your care team compare results and improve future treatment planning.
Hear when a new Aortic Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.